Cover Image

Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine

Saved in:

Bibliographic Details
Main Authors:	Alaina J. Kessler, MD, MPH (Author), Andrew Para, MD (Author), George W. Niedt, MD (Author), Paula Klein, MD (Author)
Format:	Book
Published:	Elsevier, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

My-Lupus: A case of anti-transcriptional intermediary factor 1-gamma antibody-positive dermatomyositis overlapping with discoid lupus erythematosus in an adult patient
by: Michelle Toker, BS, et al.
Published: (2023)

A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood
by: Upasana Agrawal MD, et al.
Published: (2024)

Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
by: Maria Fernanda Imperio Pereira, et al.
Published: (2024)

Anti-transcription intermediary factor 1-γ neuromyositis: A case report
by: Hui-En Chuo, et al.
Published: (2023)

Panniculitis in dermatomyositis: Two cases with antitranscriptional intermediary factor‐1 antibody as myositis‐specific antibody and review of the literature
by: Kaori Takezawa, et al.
Published: (2022)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
by: Daniel Gutierrez, MD, et al.
Published: (2022)

Refractory antimelanoma differentiation-associated gene 5 antibody negative ulcerative dermatomyositis responsive to mycophenolate mofetil
by: Sumeyye Ozer, MD, et al.
Published: (2024)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer-A Meta-Analysis
by: Zilin Zhang, et al.
Published: (2021)

Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis
by: Marion Best, et al.
Published: (2018)

Anti-NXP2 antibody positive dermatomyositis presenting as unilateral heliotrope rash
by: Zeinab F. Saleh, MD, et al.
Published: (2024)

Triple-Negative Lobular Breast Cancer Causing Hydronephrosis
by: Michael Chahin DO, et al.
Published: (2020)

Amyopathic anti‐TIF1‐γ antibody‐positive dermatomyositis in a young man
by: Nicolas Kluger
Published: (2024)

Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema
by: Lauren Chen, MS, et al.
Published: (2020)

Expanding the clinical phenotype of nuclear matrix protein 2 antibody-positive dermatomyositis
by: Michelle Toker, BS, et al.
Published: (2023)

Capecitabine safety profile, innovative and generic adjuvant formulation of nonmetastatic colorectal cancer
by: Julia Sánchez-Gundín, et al.
Published: (2019)

Overlap of Psoriatic Arthritis and Dermatomyositis
by: Christopher Schreiber MD, et al.
Published: (2021)

Refractory dermatomyositis responsive to anifrolumab
by: Phillip S. Ang, BA, et al.
Published: (2024)

Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer
by: Yuqin Lin, et al.
Published: (2023)

Dermatomyositis associated with an adrenal adenoma
by: Sherif A. Eldirany, BS, et al.
Published: (2021)

Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin
by: Eric H. Kowalski, MD, et al.
Published: (2023)

Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients
by: Matevska-Geshkovska N, et al.
Published: (2018)

Exploring Dermatomyositis through an Interdisciplinary Lens: Pearls from Dermatology and Rheumatology
by: Bina Kassamali, BA, et al.
Published: (2021)

Distinctive cutaneous features of dermatomyositis in Black adults: A case series
by: Adaeze J. Ezeofor, MD, et al.
Published: (2023)

Pioglitazone enhances cisplatin's impact on triple-negative breast cancer: Role of PPARγ in cell apoptosis
by: Qamraa Hamad Alqahtani, et al.
Published: (2024)

A Case of Paraneoplastic Anti-TIF1-γ Antibody-Positive Dermatomyositis Presenting with Generalized Edema and Associated with Aortic Aneurysm
by: Raven Bennett, et al.
Published: (2023)

Infliximab Therapy Leading to Pulmonary Tuberculosis in a Patient With Negative Interferon γ Release Assay (IGRA)-Based QuantiFERON Gold Test
by: Soni Parita MD, et al.
Published: (2017)

Recurrence of juvenile dermatomyositis 8 years after remission
by: Ken Muramatsu, MD, et al.
Published: (2017)

Getting to the bottom of it: Ulcerating gluteal plaques in dermatomyositis
by: Brittany E. Yee, MD, et al.
Published: (2020)

Dermatomyositis associated with hyponatremia and anasarca
by: Madison Grinnell, BA, et al.
Published: (2021)

Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
by: Yasmin Cura, et al.
Published: (2023)

Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis
by: Christopher J. Fay, BA, et al.
Published: (2023)

Efficacy of topical ruxolitinib for cutaneous dermatomyositis
by: Aviya Lanis, MD, et al.
Published: (2024)

Relapse or recall? Docetaxel-associated re-emergence of paraneoplastic dermatomyositis
by: Drew Kuraitis, MD, PhD, et al.
Published: (2024)

Dermatomyositis in a COVID-19 positive patient
by: Bao Vincent K. Ho, BS, et al.
Published: (2021)

Dermatomyositis-lupuslike syndrome overlap under treatment with etanercept for rheumatoid arthritis
by: Anna Lyakhovitsky, MD, et al.
Published: (2020)

Distinct purpuric lesions in patients with dermatomyositis
by: Sung Kyung Cho, BA, et al.
Published: (2021)

A Rare Case of Triple Positive Metachronous Breast Cancer
by: Hardik S. Chhatrala MD, MPH, et al.
Published: (2019)

Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
by: Victoria P. Werth, MD, et al.
Published: (2021)

Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin
by: Jason Kieffer, MD, et al.
Published: (2024)

Favorable Response to Adjuvant Tofacitinib in a Case of Anti-Melanoma Differentiation-Associated Gene-5 Antibody Positive Clinically Amyopathic Dermatomyositis
by: Nayankumar H. Patel, et al.
Published: (2024)